SBIR/STTR Research Award

Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings

Award identifier 23e9c5d715492aacf16a19c0141997406580485da665c4ca93b6d98c2cc75730Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$222,674

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PHOENIX BIOSYSTEM, INC.
Proposal award date
2016-01-01
Contract end date
2017-12-31
UEI
NXDUD4NDDQ93
Solicitation number
PA14-071
Topic code
N

Research abstract

DESCRIPTION provided by applicant Trachoma is a blinding disease caused by Chlamydia trachomatis CT Mass drug treatment with azithromycin MDA is part of the WHO endorsed andapos SAFEandapos strategy for trachoma control in endemic communities However to accurately assess the feasibility of eliminating trachoma it is essential to have a diagnostic test that can correcty measure the true status of ocular CT infection in individuals In designing the optimal regimen for antibiotic treatment it is important to know if re emergent infection represents treatment failure reinfection from untreated members of the community or reinfection from sources outside the community The most widely used test for monitoring trachoma is conjunctival examination using the WHO simplified grading system It has been shown that the positive predictive values for these tests are far lower than those of the NAAT based assays This indicates that basing treatment decisions solely on the simplified grading system will result in treatment of a considerable number of uninfected persons The commercial NAAT assays presently available are too expensive too complex or too unreliable for use in national programs There is an urgent need for a rapid cost effective reliable NAAT test for C trachomatis to assist in measuring progress towards the elimination of trachoma We propose to develop rapid accurate sensitive and cost effective NAAT based POC system to fulfill the unmet market needs in resource limited settings RLS The system can be readily expanded to include other tests for use in RLS including HIV Viral load Syphilis MGen HPV and HCV PUBLIC HEALTH RELEVANCE Trachoma is a blinding disease caused by ocular infection with CT Trachoma continues to be the target of a global effort by the WHO to eliminate the disease as a public health concern by the year Our proposed product will result in a field deployable device for diagnosis ocular CT and the system can be readily expanded to include other assays

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

27 SBIR/STTR records share this UEI (2002–2022). Reported award amounts total $7,473,973. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.